Impact of ACE Inhibitors and ARBs in Chronic Kidney Disease Management

This chapter examines a crucial study on the effectiveness of ACE inhibitors and angiotensin receptor blockers for patients with advanced chronic kidney disease and a GFR of less than 30. The meta-analysis reveals significant benefits, including reduced risks of kidney failure, advocating for these treatments in severe cases.